Lack of maternal to fetal transfer of 125I-labelled erythropoietin in sheep.
We administered tracer quantities of biologically active 125I-labelled recombinant human erythropoietin by intravenous bolus injection to seven late gestation pregnant ewes. Maternal and fetal blood was sampled over the subsequent six hours and assayed for erythropoietin-specific radioactivity. Despite the expected increase in maternal plasma immunoprecipitable 125I-labelled erythropoietin radioactivity, fetal plasma levels remained unchanged throughout the study. In addition, erythropoietin receptors were not detected in ovine and human placental tissue. We conclude that biologically active 125I-labelled erythropoietin does not cross the placenta from mother to fetus in measurable quantities in sheep, and likely in humans. Thus, these data indicate the levels of erythropoietin measured in fetal plasma are reflective of fetal, and not maternal, erythropoietin production and elimination.
Widness
J A
JA
Department of Pediatrics, University of Iowa, Iowa City 52242.
Sawyer
S T
ST
Schmidt
R L
RL
Chestnut
D H
DH
D000818:Animals; D002245:Carbon Dioxide / Q000097:blood; D046508:Culture Techniques; D004921:Erythropoietin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous / Q000662:veterinary; D008431:Maternal-Fetal Exchange; D051379:Mice; D010100:Oxygen / Q000097:blood; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D011956:Receptors, Cell Surface / Q000032:analysis; D017467:Receptors, Erythropoietin; D012756:Sheep / Q000502:physiology*
D006454:Hemoglobins; D011956:Receptors, Cell Surface; D017467:Receptors, Erythropoietin; D004921:Erythropoietin; D002245:Carbon Dioxide; D010100:Oxygen